Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 6, 2012, Pages 1321-1324

  Mendes, Rodrigo E ^a   Tsakris, Athanassios ^b   Sader, Helio S ^a   Jones, Ronald N ^a   Biek, Donald ^c   McGhee, Pamela ^d   Appelbaum, Peter C ^d   Kosowska Shick, Klaudia ^d  

^a JMI LABORATORIES   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Cerexa Inc   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Anti MRSA agents; MRSA lineages; Penicillin binding protein 2a mutations; Resistance mechanisms; ST239

Indexed keywords

BACTERIAL PROTEIN; CEFEPIME; CEFOTAXIME; CEFTAROLINE; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GAMMA GLUTAMYLTRANSFERASE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MECR1 PROTEIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN BINDING PROTEIN 2A; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; GENE CASSETTE; GENE LOCUS; GENETIC ANALYSIS; GREECE; IC 50; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; MULTIPLE LOCUS VARIABLE NUMBER TANDEM REPEAT FINGERPRINTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DOMAIN; WILD TYPE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CEPHALOSPORINS; DNA FINGERPRINTING; EXOTOXINS; GENOTYPE; GREECE; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; PENICILLIN-BINDING PROTEINS; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS;

EID: 84861161243     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks069     Document Type: Article

References (13)

1. Jones RN, Mendes RE, Sader HS. Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study. J Antimicrob Chemother 2010; Suppl 4: iv17-31.
2. Georgopapadakou NH. Penicillin-binding proteins and bacterial resistance to b-lactams. Antimicrob Agents Chemother 1993; 37: 2045-53.
3. Chambers HF. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J Infect Dis 1999; 179 Suppl 2: S353-9.
4. Mushtaq S, Warner M, Ge Y et al. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. J Antimicrob Chemother 2007; 60: 300-11.
5. Shopsin B, Gomez M, Montgomery SO et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37: 3556-63.
6. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
7. Sabat A, Krzyszton-Russjan J, Strzalka W et al. New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J Clin Microbiol 2003; 41: 1801-4.
8. Mendes RE, Sader HS, Deshpande LM et al. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. J Clin Microbiol 2010; 48: 568-74.
9. Kosowska-Shick K, McGhee PL, Appelbaum PC. Affinity of ceftaroline and other β-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother 2010; 54: 1670-7.
10. Lim D, Strynadka NCJ. Structural basis for the β-lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat Struct Biol 2002; 9: 870-6.
11. Banerjee R, Gretes M, Basuino L et al. In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52: 2089-96.
12. Katayama Y, Zhang H-Z, Chambers HF. PBP 2a mutations producing very-high-level resistance to β-lactams. Antimicrob Agents Chemother 2004; 48: 453-9.
13. Ender M, McCallum N, Berger-Bächi B. Impact of mecA promoter mutations on mecA expression and b-lactam resistance levels. Int J Med Microbiol 2008; 298: 607-17.